As a result, coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively (Table 1)
BPC-157 is a 15-amino-acid peptide studied for its regenerative effects, including: Accelerated wound healing 10 Tendon & ligament repair 14 Gut health improvement (leaky gut, IBS support) 6 Neuroprotective benefits (potential for brain injury recovery) 10 Anti-inflammatory & pain relief (joints, muscles) 5 Due to these benefits, demand has surgedbut so have scams and mislabeled products
These probiotics for digestive health combine synbiotics (pre and probiotics for women and men), postbiotics, FOS (Fructooligosaccharides) prebiotic and vitamin B12 to support digestion, energy, and mood
Gleichermaen knnte NaBPC157 die Folge von durch Haloperidol blockierten Dopaminrezeptoren deutlich abschwchen